Unlimited Science, a psychedelics non-profit R&D organization, is collaborating with Johns Hopkins.
Unlimited Science, a psychedelics non-profit R&D organization, is collaborating with Johns Hopkins.
MindMed reported a net loss of $5.8 million for first 6 months of 2020, has USD $24 million in cash.
Among publicly listed companies in the psychedelics space, most are psychedelics-cannabis hybrids. It actually makes a lot of sense.
Tryp Therapeutics adds a partner to advance its drug manufacturing capabilities.
MindMed's new President will be expanding the company's R&D footprint in Europe and leading Project Lucy.
A new psychedelics company began trading August 11th.
Mydecine's corporate update notes its "world's first" clinical trials initiative for PTSD.
There are obvious parallels between cannabis and psychedelics decriminalization. Are there are also differences?
PharmaDrug takes its first step to begin retail psychedelic sales in the legal market for psychedelic drugs in the Netherlands.
Revive develops a new tannin-chitosan composite as a psychedelics delivery system.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now